<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05069883</url>
  </required_header>
  <id_info>
    <org_study_id>AF1</org_study_id>
    <nct_id>NCT05069883</nct_id>
  </id_info>
  <brief_title>Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy</brief_title>
  <official_title>Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Services Hospital, Lahore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Armed Forces Institute of Urology, Rawalpindi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Services Hospital, Lahore</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      It was a randomized controlled trial conducted at department of Urology, Armed Forces&#xD;
      Institute of Urology, Rawalpindi from 1st January, 2018 July 2019 to 31st March 2021 to&#xD;
      determine the role of oral steroids after Direct Vision Internal Urethrotomy to reduce the&#xD;
      recurrence rate of urethral strictures.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">March 31, 2021</completion_date>
  <primary_completion_date type="Actual">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of Urethral Stricture</measure>
    <time_frame>6 months post-operatively</time_frame>
    <description>Number of patients presenting with recurrence of urethral stricture after direct vision internal urethrotomy</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Recurrence</condition>
  <arm_group>
    <arm_group_label>Oral Steroid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group oral steroids were given after Direct vision internal urethrotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Oral Steroids</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In this group no oral steroids were given after Direct vision internal urethrotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Steroid Drug</intervention_name>
    <description>In this group Oral steroid medication after Direct Vision Internal Urethrotomy</description>
    <arm_group_label>Oral Steroid</arm_group_label>
    <other_name>Oral steroid medication</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>No steroid</intervention_name>
    <description>In this group no Oral steroid medication (palcebo medication) after Direct Vision Internal Urethrotomy</description>
    <arm_group_label>No Oral Steroids</arm_group_label>
    <other_name>Placebo Medication</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with urethral stricture with restricted urine flow of &lt; 15 ml/min on&#xD;
             uroflowmetry&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients presenting with post-anastomotic urethroplasty strictures (assessed on&#xD;
             history and medical record),&#xD;
&#xD;
          -  Patients with post-TURP strictures&#xD;
&#xD;
          -  Patients with neurogenic bladder&#xD;
&#xD;
          -  Patients with prior history of steroid use&#xD;
&#xD;
          -  Patients with extravasation during optical internal urethrotomy&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barza Afzal, MBBS, FCPS</last_name>
    <role>Study Director</role>
    <affiliation>barza_afzal@hotmail.com</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Armed Force Institute of Urology</name>
      <address>
        <city>Rawalpindi</city>
        <state>Punjab</state>
        <zip>54000</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>September 26, 2021</study_first_submitted>
  <study_first_submitted_qc>September 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2021</study_first_posted>
  <last_update_submitted>September 26, 2021</last_update_submitted>
  <last_update_submitted_qc>September 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Services Hospital, Lahore</investigator_affiliation>
    <investigator_full_name>Dr. SamiUllah</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urethral Stricture</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

